UK REVIEWS NHS-PALANTIR CONTRACT AMID US TECH RELIANCE CONCERNS

The UK government has initiated a comprehensive review of its NHS partnership with Palantir Technologies, the data analytics company founded by Peter Thiel. The contract, which processes sensitive health data, has faced increasing scrutiny from lawmakers and privacy advocates. Critics argue the arrangement creates problematic reliance on US-based technology for critical national infrastructure. Concerns center on data sovereignty, potential access by US authorities, and the strategic implications of outsourcing healthcare analytics to a foreign firm. The review is expected to assess whether the NHS can develop or transition to domestically controlled alternatives before the contract's potential termination in 2027. Officials will evaluate the technical feasibility, costs, and timeline for such a shift. Palantir has processed NHS data since 2021, supporting pandemic response efforts and subsequent health operations. The company maintains it operates within UK regulatory frameworks and data protection laws.